论文信息 - Atrial Fibrillation (Update on Dabigatran) 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With - 字舞流文

Atrial Fibrillation (Update on Dabigatran) 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With

M. Ezekowitz | C. January | L. Wann | A. Curtis | J. Lowe | R. Page | W. Jackman | M. Estes | D. Slotwiner | G. William

[1] S. Yusuf,et al. Newly identified events in the RE-LY trial. , 2010, The New England journal of medicine.

[2] B. Gage. Can we rely on RE-LY? , 2009, The New England journal of medicine.

[3] S. Yusuf,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[4] W. Weaver,et al. Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial , 2003, The Lancet.

[5] Silvia G. Priori,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .